MedTrace Logo

Prehab Prior to Undergoing Tricuspid Intervention

NCT04665583 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2022-09-23

No results posted yet for this study

Summary

This study will aim to standardize the prehabilitation protocol to optimize patients and document the clinical and echo variables that could improve clinical outcomes of tricuspid valve intervention.

Conditions

  • Tricuspid Valve Disease
  • Tricuspid Regurgitation

Interventions

OTHER

Prehabilitation

Prehabilitation will consist of careful pre-intervention assessment and personalized optimization, guided by Investigator judgment, with a specific focus on right ventricular function. This will be done by using a detailed echo acquisition protocol (Appendix 1). Assessments will be collected according to the schedule of events below (Table 1.). Therapy will include intravenous milrinone therapy and aggressive diuresis with evaluation for clinical and functional signs of improvement, according to standard of care.

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-25
Primary Completion
2021-11-01
Completion
2021-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04665583 on ClinicalTrials.gov